CVS Group plc (LON:CVSG) Receives Average Recommendation of “Moderate Buy” from Analysts

CVS Group plc (LON:CVSG) has earned an average recommendation of “Moderate Buy” from the six brokerages that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have covered the stock in the last year is GBX 1,666.67.

Several equities analysts have recently issued reports on CVSG shares. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 1,700 price objective on shares of CVS Group in a report on Monday, July 27th. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 2,000 price target on shares of CVS Group in a report on Thursday. Jefferies Financial Group lifted their price objective on shares of CVS Group from GBX 1,350 to GBX 1,400 and gave the stock a “hold” rating in a research note on Friday, July 31st. Finally, Shore Capital Group reissued a “hold” rating and issued a GBX 1,400 target price on shares of CVS Group in a research report on Thursday.

Insider Transactions at CVS Group

In other CVS Group news, insider Joanne Shaw purchased 1,592 shares of the stock in a transaction on Monday, August 10th. The shares were bought at an average cost of GBX 1,287 per share, with a total value of £20,489.04. Also, insider David Wilton purchased 1,500 shares of the business’s stock in a transaction on Tuesday, August 4th. The shares were bought at an average cost of GBX 1,276 per share, for a total transaction of £19,140. Insiders bought a total of 3,860 shares of company stock worth $4,956,696 over the last three months. 1.48% of the stock is currently owned by insiders.

CVS Group Trading Down 6.5%

CVSG opened at GBX 1,217.04 on Thursday. CVS Group has a 12 month low of GBX 1,062 and a 12 month high of GBX 1,648. The stock has a fifty day moving average price of GBX 1,289.88 and a 200-day moving average price of GBX 1,230. The firm has a market cap of £827.22 million, a price-to-earnings ratio of 17.66, a PEG ratio of 1.77 and a beta of 1.07. The company has a current ratio of 1.07, a quick ratio of 0.90 and a debt-to-equity ratio of 92.34.

CVS Group (LON:CVSG) last issued its quarterly earnings data on Thursday, September 24th. The company reported GBX 85.60 earnings per share (EPS) for the quarter. CVS Group had a net margin of 2.31% and a return on equity of 5.35%. As a group, equities research analysts anticipate that CVS Group will post 93.9393939 earnings per share for the current fiscal year.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.